Latest News & Updates
Exclusive Access for In-House Counsel
Qualified applicants may attend at no cost—apply now to reserve your place.
Enquire NowEurope’s Premier Forum for Life Sciences Product Liability, Policy & Dispute Resolution
For more than three decades, C5 has convened senior product liability and medical device litigators through its long-standing New York conference, creating a trusted environment for candid discussion of complex disputes.
Life Sciences Product Liability, Policy & Dispute Resolution Europe builds on that foundation, bringing the same discussion-driven, peer-level format to Brussels. This essential forum delivers a rare, defense-first lens on emerging EU liability, evidence, and cross-border risks – equipping in-house teams and external counsel with the strategies they need as Europe enters a more aggressive enforcement and collective-action era.
The program covers EU product-liability, class action, and mass-harm trends post-PLD, safety/vigilance & recalls, labeling and promotion disputes, and coordination across Member State procedures – giving attendees a comprehensive view of the most urgent litigation pressures facing life sciences companies today.
View Agenda
Conference Co-Chairs
Lisa M. Baird
Partner
Reed Smith LLP (USA)
Dr. Christian Rybak
Shareholder
Greenberg Traurig Germany, LLP (Germany)
Featured Keynote Speakers
Katrin Saaremäel
Legal and Policy Officer at DG Internal Market, Industry, Entrepreneurship and SMEs
European Commission (Belgium)
Prof. Duncan Fairgrieve KC
Université Paris-Dauphine & BIICL, Avocat à la Cour, Paris & Barrister England & Wales
(France)
View All Speakers
Event Highlights
New EU Product-Liability Rules: What’s Changing and How To Defend
Collective Actions & Litigation Funding
Pricing & Reimbursement Disputes
AI in Devices & Diagnostics
Device-Safety Files as Evidence
Health-Data and Cross-Border Discovery
Settlements & Case Studies: Lessons from U.S. and EU actions
GC Roundtable: 12-Month Defense Readiness Checklist
Why Europe is Now the Epicenter of Life Sciences Litigation
Europe is entering a more aggressive phase for drug and device disputes, driven by a perfect storm of regulatory expansion, technical transparency, and coordinated claimant activity. The new EU Product Liability Directive (PLD) will widen the scope of who can be sued, open access to internal documents, and capture software, AI, components, and additional economic operators. At the same time, the EU AI Act and European Health Data Space are creating structured technical and data trails that will inevitably be requested in litigation.
Across the region, pricing and reimbursement pressures – including “most-favoured nation” rules, claw backs, and refusals – are triggering high-stakes conflicts. And with the rise of collective redress mechanisms and third-party funders, coordinated claims are becoming more realistic and far more expensive to ignore.
This is no longer a niche conversation. Legal, regulatory, and commercial teams need a European defense playbook before PLD transposition, AI Act requirements, and pricing disputes converge through 2026–27.
Who Should Attend
Product-liability counsel, litigation and risk leaders, insurers, claims managers, and external defense counsel aligning EU and global strategies.
Sponsors & Partners
Supporting Sponsor
Associate Sponsors
Media Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
